Our Client is a HOT emerging specialty BIOPHARM start up primarily focused on the development and commercialization of late clinical-stage, proprietary, orally administered, small molecule drugs for the treatment of Gastrointestinal and inflammatory diseases, including cancer.
Our client has 9 drugs in advanced clinical developments stages. Lead by a TOP NOTCH executive leadership team from Harvard, Yale, and Oxford, who have successful track records bringing patented drugs to the market.
** Start up opportunity with Equity play
** Get in on the ground floor of a publicly traded company new to the US
** Generous compensation package
** Tremendous growth opportunities within the US and abroad
1-3 years of leadership Pharmaceutical Industry
Working knowledge of GI Space and start up experience a plus (National Sales training experience)